Texas

The deal has a flexible framework, which will allow for a variety of projects at different stages of development over several years.

The pooled data results came five months after the FDA rejected Zynquista following a split advisory committee vote.

Although anti-retroviral therapies have come a long way in turning HIV into being treated like a chronic, manageable disease, researchers are still attempting to find something that might be considered a cure, which would completely eradicate the virus. Researchers from University of Texas Medical Branch at Galveston may have found a way.

Guardant Health, along with researchers with MD Anderson Cancer Center, the Samsung Medical Center and others, conducted a large study that showed the Guardant360 assay can accurately detect MSI.

According to a BioSpace poll, approximately 86% of life science respondents are on the verge of job burnout. Are you one of the 86%? Does this mean you need to start looking for a new job? This is definitely one of your options. Start here to look at all of the great opportunities out there in the life science industry!

An experimental vaccine for respiratory syncytial virus (RSV) showed positive results in a Phase I clinical trial. Researchers from The University of Texas at Austin and others reported that a single dose of the vaccine produced significant evidence of RSV-neutralizing antibodies that were sustained for several months.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Researchers from UT Southwestern discovered that PARP inhibitors can also impact the cellular production of ribosomes, a protein cancer cells depend upon.

There’s clearly a need for new antibiotics to fight infections. If so, why are so many companies in the space abandoning it or going out of business?

In its third installment of the Good Pharma Scorecard, Roche and Novo Nordisk scored perfect marks in overall trial transparency, while Johnson & Johnson slipped from the high spot on the previous ranking.